Morgan Keegan is out with a research report on Alliance HealthCare Services AIQ and it has a Market Perform rating and a $4.75 price target on shares as it previews earnings.
In a note to clients, Morgan Keegan writes, "Our adjusted EBITDA estimate is $43 million, up slightly from $42.5 million in the prior year period. We consider this a better indicator of profitability than EPS due to high amounts of
noncash depreciation and amortization. Our EPS estimate of $0.00 is in line with the First Call consensus."
Shares of AIQ gained 25 cents on Friday to close at $3.61.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in